Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AVI ND LaSota is a live attenuated veterinary vaccine containing the LaSota strain of Newcastle Disease Virus (NDV). Developed and manufactured by Laprovet (a subsidiary of Ceva Santé Animale) and distributed in various regions including by Navana Pharmaceuticals in Bangladesh, the vaccine is indicated for the active immunization of healthy chickens (including broilers, pullets, and breeders) against Newcastle disease. It is administered via oculonasal (eye drops), drinking water, or nebulization (spray) routes to stimulate protective immunity against the highly contagious viral pathogen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AVI ND LaSota.